Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 5 |
| 1.1 List of Tables | 4 | 2 |
| 1.2 List of Figures | 6 | 1 |
| 2 Introduction | 7 | 1 |
| 2.1 Peripheral Embolic Protection Devices Overview | 7 | 1 |
| 3 Products under Development | 8 | 6 |
| 3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development | 8 | 1 |
| 3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment | 9 | 1 |
| 3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory | 10 | 1 |
| 3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path | 11 | 1 |
| 3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date | 12 | 1 |
| 3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials | 13 | 1 |
| 4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies | 14 | 2 |
| 4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development | 14 | 1 |
| 4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development | 15 | 1 |
| 5 Peripheral Embolic Protection Devices Companies and Product Overview | 16 | 38 |
| 5.1 Abbott Vascular Inc. Company Overview | 16 | 1 |
| 5.1.1 Abbott Vascular Inc. Pipeline Products &Ongoing Clinical Trials Overview | 16 | 2 |
| 5.2 Avantec Vascular Corporation Company Overview | 18 | 1 |
| 5.2.1 Avantec Vascular Corporation Pipeline Products &Ongoing Clinical Trials Overview | 18 | 1 |
| 5.3 Cardio-Flow Ltd. Company Overview | 19 | 1 |
| 5.3.1 Cardio-Flow Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 19 | 1 |
| 5.4 CardioGard Ltd. Company Overview | 20 | 1 |
| 5.4.1 CardioGard Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 20 | 3 |
| 5.5 Claret Medical, Inc. Company Overview | 23 | 1 |
| 5.5.1 Claret Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 3 |
| 5.6 EKOS Corporation Company Overview | 26 | 1 |
| 5.6.1 EKOS Corporation Pipeline Products &Ongoing Clinical Trials Overview | 26 | 6 |
| 5.7 EMBA Medical Limited Company Overview | 32 | 1 |
| 5.7.1 EMBA Medical Limited Pipeline Products &Ongoing Clinical Trials Overview | 32 | 3 |
| 5.8 Inari Medical, Inc. Company Overview | 35 | 1 |
| 5.8.1 Inari Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 35 | 3 |
| 5.9 Innovative Cardiovascular Solutions, LLC Company Overview | 38 | 1 |
| 5.9.1 Innovative Cardiovascular Solutions, LLC Pipeline Products &Ongoing Clinical Trials Overview | 38 | 2 |
| 5.10 Innovia LLC Company Overview | 40 | 1 |
| 5.10.1 Innovia LLC Pipeline Products &Ongoing Clinical Trials Overview | 40 | 1 |
| 5.11 Keystone Heart Ltd. Company Overview | 41 | 1 |
| 5.11.1 Keystone Heart Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 41 | 4 |
| 5.12 Medtronic plc Company Overview | 45 | 1 |
| 5.12.1 Medtronic plc Pipeline Products &Ongoing Clinical Trials Overview | 45 | 2 |
| 5.13 Metactive Medical, LLC Company Overview | 47 | 1 |
| 5.13.1 Metactive Medical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 47 | 1 |
| 5.14 MIV Therapeutics Inc Company Overview | 48 | 1 |
| 5.14.1 MIV Therapeutics Inc Pipeline Products &Ongoing Clinical Trials Overview | 48 | 1 |
| 5.15 Neurosonix Ltd. Company Overview | 49 | 1 |
| 5.15.1 Neurosonix Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 49 | 1 |
| 5.16 Trinity College Dublin Company Overview | 50 | 1 |
| 5.16.1 Trinity College Dublin Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
| 5.17 University of Minnesota Company Overview | 51 | 1 |
| 5.17.1 University of Minnesota Pipeline Products &Ongoing Clinical Trials Overview | 51 | 1 |
| 5.18 University of Toledo Company Overview | 52 | 1 |
| 5.18.1 University of Toledo Pipeline Products &Ongoing Clinical Trials Overview | 52 | 2 |
| 6 Peripheral Embolic Protection Devices- Recent Developments | 54 | 30 |
| 6.1 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer | 54 | 1 |
| 6.2 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results | 54 | 1 |
| 6.3 Oct 03, 2016: American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR | 55 | 1 |
| 6.4 Sep 20, 2016: Claret Medical Submits Marketing Application to FDA for US Clearance of First Cerebral Protection System for Transcatheter Aortic Valve Replacement (TAVR) | 56 | 1 |
| 6.5 Sep 19, 2016: TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures | 57 | 1 |
| 6.6 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services | 58 | 1 |
| 6.7 Sep 14, 2016: Claret Medical Announces SENTINEL Pivotal IDE Trial to Be Featured in Late-Breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference | 59 | 1 |
| 6.8 Aug 30, 2016: MPSC Announces 2016 Interim Results | 60 | 1 |
| 6.9 Aug 25, 2016: Medtronic Reports First Quarter Financial Results | 61 | 3 |
| 6.10 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results | 64 | 1 |
| 6.11 Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares | 64 | 1 |
| 6.12 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 65 | 1 |
| 6.13 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results | 66 | 2 |
| 6.14 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer | 68 | 1 |
| 6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 68 | 1 |
| 6.16 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results | 69 | 1 |
| 6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic | 70 | 1 |
| 6.18 Jun 15, 2016: Keystone Heart Announces First Patient Enrolled in New Study to Protect the Brain During TAVR | 70 | 1 |
| 6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 71 | 1 |
| 6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day | 72 | 1 |
| 6.21 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results | 72 | 3 |
| 6.22 May 31, 2016: Keystone Heart Appoints New President and Chief Executive Officer | 75 | 1 |
| 6.23 May 19, 2016: TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients Neurological Outcomes in TAVR Procedures | 75 | 1 |
| 6.24 May 09, 2016: Penumbra Reports First Quarter 2016 Financial Results | 76 | 1 |
| 6.25 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results | 76 | 2 |
| 6.26 Mar 31, 2016: Penumbra to Present Final Results of Multicenter Prism Trial on Indigo System at SIR 2016 | 78 | 1 |
| 6.27 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device | 78 | 1 |
| 6.28 Mar 08, 2016: Inari Medical Announces IDE Approval To Study The Flowtriever System For The Treatment Of Pulmonary Embolism | 78 | 1 |
| 6.29 Feb 02, 2016: EndoShape Raises USD7 Million in Venture Financing | 79 | 1 |
| 6.30 Jan 06, 2016: Penumbra Introduces POD Packing Coil for the Embolization of Peripheral Vessels and Aneurysms | 79 | 1 |
| 6.31 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved | 80 | 1 |
| 6.32 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment | 80 | 1 |
| 6.33 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference | 81 | 1 |
| 6.34 Nov 23, 2015: Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award | 82 | 1 |
| 6.35 Nov 18, 2015: EMBA Medical Cleared to Market Hourglass Peripheral Embolization Plug in New Zealand | 82 | 2 |
| 7 Appendix | 84 | 4 |
| 7.1 Methodology | 84 | 2 |
| 7.2 About GlobalData | 86 | 1 |
| 7.3 Contact Us | 86 | 1 |
| 7.4 Disclaimer | 87 | 1 |